SAR# [002]

Related by string. SAR# [001] . SAR# [003] . SAR# [004] * * XL# SAR# *

Related by context. Frequent words. (Click for all words.) 71 MEK inhibitor 71 Guanilib 71 AVE# 70 liposomal formulation 70 TLR9 agonist 70 Sym# 69 proteasome inhibitor 69 Cetrorelix 69 orally bioavailable 68 SAR# [004] 68 MKC# 68 CCX# 68 PSN# [002] 68 Drug Candidate 68 ATL# [001] 67 Initiate Phase 67 Recombinant Human 67 Mipomersen 67 Panzem R 67 Factor VIIa 67 Pivotal Phase III 67 zileuton 67 GLPG# 67 Initiates Phase 66 elotuzumab 66 novel orally administered 66 therapeutic monoclonal antibodies 66 IMC #B 66 Aliskiren 66 Zolinza 66 Phase III Clinical Trial 66 Presents Positive 66 Monoclonal Antibody 66 ASONEP 66 Dasatinib 66 LY# [002] 66 Metastatic Melanoma 66 humanized anti 66 Azedra 66 anticancer compound 66 HCV protease inhibitor 65 LY# [003] 65 Tesetaxel 65 Laquinimod 65 epothilone 65 MNTX 65 PEG SN# 65 Belimumab 65 Onalta 65 cancer immunotherapies 65 nitric oxide donating 65 PEGylated 65 CORT # 65 Traficet EN 65 HuMax CD# 65 Icatibant 65 Epratuzumab 65 Completes Enrollment 65 DDP# 65 proteasome inhibitors 65 Pivotal Phase 65 vascular disrupting agent 64 SARMs 64 thymalfasin 64 humanized monoclonal antibody 64 HCV protease 64 INCB# [001] 64 Carfilzomib 64 CYC# 64 tezampanel 64 Bicifadine 64 JAK3 64 SRT# [003] 64 Avanafil 64 Advancing Drugs 64 multi kinase inhibitor 64 Eltrombopag 64 RGB # 64 Naproxcinod 64 deforolimus 64 Clinical Trial Results 64 humanized antibody 64 topical anti infective 64 Benign Prostatic Hyperplasia 64 immunomodulator 64 diabetic neuropathic pain 64 luteinizing hormone releasing 63 prodrugs 63 subcutaneous formulation 63 Idera Pharmaceuticals 63 selectively inhibits 63 pertuzumab 63 polymerase inhibitors 63 phase IIb 63 immunomodulatory 63 tanespimycin 63 novel antibody therapeutics 63 tyrosine kinase inhibitor 63 Diamyd ® 63 SCH # 63 investigational compounds

Back to home page